Cleveland's data shows approval times climbed amid the COVID-19 pandemic, and officials are still trying to push the trend ...

As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...

The clinical-stage biotech could see its shares plummet should there be any clinical setback.

In Altadena, the community continues to rebuild one year after the Eaton Fire. We spoke with one family about their hopes for ...

Across suburban Chicago, many people will start new businesses this year, and many of them will have more than one owner.

Walk through any big city on a Friday and you can feel it. Some office streets are quieter than they used to be. At the same ...

As the Minneapolis killing gets darker for Trump, Representatives Eric Swalwell and Dan Goldman talk about their plan to ...

Australia’s next National Defence Strategy (NDS) risks overlooking a crucial vulnerability that’s hiding in plain sight: our ...

Many companies are choosing to build their own AI systems, rather than buy. Financial services firm Kapitus shares lessons learned.

Biotech companies that will lead the next decade wont just have better science, theyll have superior operating models, writes ...

Supreme Court occupied with one much-debated and discussed issue : Special Intensive Revision, the 'SIR'.The bench of CJI ...

At the CIO100 Symposium, Avnet CIO Max Chan talked with host Lucas Mearian about how AI underpins sales enablement, ...